Want to join the conversation?
$LLY lowered its 2016 EPS guidance to range of $2.83-2.93 from previous forecast of $2.92-3.02. $LLY still expects 2016 non-GAAP EPS of $3.45-3.55, which exclude amortization of intangibles as well as integration costs associated with Novartis Animal Health acquisition. $LLY still sees 2016 revenue of $20.2-20.7Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?